This SuperSeries is composed of the SubSeries listed below.
Overall design: Refer to individual Series
| Accession | PRJNA523724; GEO: GSE126918 |
| Type | Umbrella project |
| Publications | Zhang Z et al., "Loss of CHD1 Promotes Heterogeneous Mechanisms of Resistance to AR-Targeted Therapy via Chromatin Dysregulation.", Cancer Cell, 2020 Apr 13;37(4):584-598.e11 |
| Submission | Registration date: 22-Feb-2019
Charles L. Sawyers Lab, Human Oncology and Pathogenesis, Memorial Sloan Kettering Cancer Center |
| Relevance | Superseries |
Project Data:
| Resource Name | Number
of Links |
|---|
| Sequence data |
| SRA Experiments | 453 |
| Publications |
| PubMed | 1 |
| PMC | 1 |
| Other datasets |
| BioSample | 453 |
| GEO DataSets | 4 |
Loss of CHD1 promotes chromatin dysregulation leading to heterogeneous mechanisms of resistance to hormone therapy in prostate cancer encompasses the following 3 sub-projects:
| Project Type | Number of Projects |
| Epigenomics | 1 |
BioProject
accession | Organism | Title |
|---|
| PRJNA524393 | Homo sapiens | Loss of CHD1 promotes chromatin dysregulation leading to heterogeneous mechanisms of resistance to hormone therapy in prostate cancer [ATAC-seq] (Charles L. Sawyers Lab, Human...) |
|
| Other | 1 |
BioProject
accession | Name | Title |
|---|
| PRJNA525865 | Loss of CHD1 promotes chromatin dysregulation leading to heterogeneous mechanisms of resistance to hormone therapy in prostate cancer [shRNA screen] | Loss of CHD1 promotes chromatin dysregulation leading to heterogeneous mechanisms of resistance to hormone therapy in prostate cancer [shRNA screen] (Charles L. Sawyers Lab, Human...) |
|
| Transcriptome or Gene expression | 1 |
BioProject
accession | Organism | Title |
|---|
| PRJNA523728 | Homo sapiens | Loss of CHD1 promotes chromatin dysregulation leading to heterogeneous mechanisms of resistance to hormone therapy in prostate cancer [RNA-seq] (Charles L. Sawyers Lab, Human...) |
|